Eduardo Martins-Dias

Is the adenosine A2B 'biased' receptor a valuable target for the treatment of pulmonary arterial hypertension?

P. Correia‐de‐Sá, M. Bessa-Gonçalves, A. Fontes-Sousa, 2018, Drug discovery today.

Blockage of the adenosine A2B receptor prevents cardiac fibroblasts overgrowth in rats with pulmonary arterial hypertension

P. Correia‐de‐Sá, M. Bessa-Gonçalves, A. Fontes-Sousa, 2023, Purinergic signalling.